Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 1276 AL 1290

Inference of brain networks with approximate Bayesian computation - assessing face validity with an example application in Parkinsonism

West TO, Berthouze L, Farmer SF, Cagnan H, Litvak V.

Neuroimage. 2021 Aug 1;236:118020. doi: 10.1016/j.neuroimage.2021.118020. Epub 2021 Apr 9.

Systemic Review on Transcranial Electrical Stimulation Parameters and EEG/fNIRS Features for Brain Diseases

Yang D, Shin YI, Hong KS.

Front Neurosci. 2021 Mar 26;15:629323. doi: 10.3389/fnins.2021.629323. eCollection 2021.

Phosphoinositides: Roles in the Development of Microglial-Mediated Neuroinflammation and Neurodegeneration

Ernest James Phillips T, Maguire E.

Front Cell Neurosci. 2021 Mar 26;15:652593. doi: 10.3389/fncel.2021.652593. eCollection 2021.

Successful Management of Parkinson's Disease Dyskinesia During Local Anesthesia With Dexmedetomidine

Nakajima T, Suzuki Y, Miyaue N.

Cureus. 2021 Mar 6;13(3):e13739. doi: 10.7759/cureus.13739.

Exploring the Use of Intracranial and Extracranial (Remote) Photobiomodulation Devices in Parkinson's Disease: A Comparison of Direct and Indirect Systemic Stimulations

Johnstone DM, Hamilton C, Gordon LC, Moro C, Torres N, Nicklason F, Stone J, Benabid AL, Mitrofanis J.

J Alzheimers Dis. 2021;83(4):1399-1413. doi: 10.3233/JAD-210052.

Vacuum-Assisted Closure with Temporalis Muscle Reconstruction for Recurrent Scalp Erosion Following Deep Brain Stimulation: A Case Report

Oh BH, Park YY, Park JK, Park YS.

J Parkinsons Dis. 2021;11(3):1465-1469. doi: 10.3233/JPD-212651.

Nrf2 as a potential target for Parkinson's disease therapy

Niu Y, Zhang J, Dong M.

J Mol Med (Berl). 2021 Jul;99(7):917-931. doi: 10.1007/s00109-021-02071-5. Epub 2021 Apr 12.

[Health risks related to milk consumption: a critical evaluation from the medical perspective]

Melnik BC, Schmitz G, John SM.

MMW Fortschr Med. 2021 Apr;163(Suppl 4):3-9. doi: 10.1007/s15006-021-9652-x.

Diabetes, insulin and new therapeutic strategies for Parkinson's disease: Focus on glucagon-like peptide-1 receptor agonists

Labandeira CM, Fraga-Bau A, Arias Ron D, Muñoz A, Alonso-Losada G, Koukoulis A, Romero-Lopez J, Rodriguez-Perez AI.

Front Neuroendocrinol. 2021 Jul;62:100914. doi: 10.1016/j.yfrne.2021.100914. Epub 2021 Apr 15.

The cannabinoid system and microglia in health and disease

Duffy SS, Hayes JP, Fiore NT, Moalem-Taylor G.

Neuropharmacology. 2021 Jun 1;190:108555. doi: 10.1016/j.neuropharm.2021.108555. Epub 2021 Apr 9.

Potential of Medicinal Plants as Neuroprotective and Therapeutic Properties Against Amyloid-β-Related Toxicity, and Glutamate-Induced Excitotoxicity in Human Neural Cells

Lobine D, Sadeer N, Jugreet S, Suroowan S, Keenoo BS, Imran M, Venugopala KN, Ibrahim FM, Zengin G, Mahomoodally MF.

Curr Neuropharmacol. 2021;19(9):1416-1441. doi: 10.2174/1570159X19666210412095251.

Synucleinopathy-associated pathogenesis in Parkinson's disease and the potential for brain-derived neurotrophic factor

Miller KM, Mercado NM, Sortwell CE.

NPJ Parkinsons Dis. 2021 Apr 12;7(1):35. doi: 10.1038/s41531-021-00179-6.

Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?

Akdis CA.

Nat Rev Immunol. 2021 Nov;21(11):739-751. doi: 10.1038/s41577-021-00538-7. Epub 2021 Apr 12.

Suppression head impulse test paradigm (SHIMP) characteristics in people with Parkinson's disease compared to healthy controls

Hawkins KE, Rey-Martinez J, Chiarovano E, Paul SS, Valldeperes A, MacDougall HG, Curthoys IS.

Exp Brain Res. 2021 Jun;239(6):1853-1862. doi: 10.1007/s00221-021-06107-7. Epub 2021 Apr 12.

Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment

Asefy Z, Hoseinnejhad S, Ceferov Z.

Neurol Sci. 2021 Jul;42(7):2653-2660. doi: 10.1007/s10072-021-05234-x. Epub 2021 Apr 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias